The Effects of CBT and tDCS on Fibromyalgia Patients
| Status: | Completed |
|---|---|
| Conditions: | Chronic Pain, Chronic Pain, Fibromyalgia, Pain |
| Therapuetic Areas: | Musculoskeletal, Rheumatology |
| Healthy: | No |
| Age Range: | 21 - 85 |
| Updated: | 11/30/2018 |
| Start Date: | December 2014 |
| End Date: | September 2017 |
The Effects of Cognitive Behavioral Therapy (CBT) and Transcranial Direct Current Stimulation (tDCS) on Fibromyalgia Patients
Investigators are seeking to determine the effects of CBT, anodal tDCS over left DLPFC, and
combined CBT+ tDCS on clinical pain and functioning among a sample of patients with
fibromyalgia. This study will be the first randomized, double-blind, controlled study of tDCS
technology as an adjunctive pain management strategy for fibromyalgia pain. Data from this
trial will likely yield information regarding the feasibility and efficacy of tDCS+CBT as a
chronic pain-management approach.
combined CBT+ tDCS on clinical pain and functioning among a sample of patients with
fibromyalgia. This study will be the first randomized, double-blind, controlled study of tDCS
technology as an adjunctive pain management strategy for fibromyalgia pain. Data from this
trial will likely yield information regarding the feasibility and efficacy of tDCS+CBT as a
chronic pain-management approach.
Patients with fibromyalgia will complete questionnaires, six cognitive behavioral therapy
sessions, quantitative sensory testing before and after the six therapy sessions, and undergo
30 minutes of tDCS during each of the six therapy sessions.
sessions, quantitative sensory testing before and after the six therapy sessions, and undergo
30 minutes of tDCS during each of the six therapy sessions.
Inclusion Criteria:
1. Meet the American College of Rheumatology criteria for diagnosis of fibromyalgia for
at least 1 year.
2. Between the ages of 21 and 85
Exclusion Criteria:
1. Other chronic pain conditions
2. on chronic opioid therapy
3. history of seizures
4. are or might be pregnant
5. metal/electronic implants or devices above the waist
6. moderate to severe depression (HDRS >19)
7. moderate to severe anxiety (BAI >16)
8. Latex allergy
9. Psychiatric illness other than mild depression or anxiety
10. on medications that lower seizure threshold
We found this trial at
1
site
171 Ashley Avenue
Charleston, South Carolina 29425
Charleston, South Carolina 29425
843-792-1414
Principal Investigator: Jeffery Borckardt, PhD
Phone: 843-792-3127
Medical University of South Carolina The Medical University of South Carolina (MUSC) has grown from...
Click here to add this to my saved trials
